Applications
The RDRC Application for Human Subject Research Using Research Radioactive Drug must be submitted with application to the RDRC for review and recommendation to the RSC. RDRC applications are completed through PROTECT. In addition to the RDRC application, copies of the protocol, consent, assent (if applicable), and dosimetry tables must be included. More information on submitting a Clinical Protocol application can be found in the Clinical Protocol Information section.
For additional guidance, contact the RDRC Chair Teresa Fisher at (301) 496-2253 or teresa.fisher@nih.gov.
